
Rabenoj-DSR
January 14, 2025
Nuroswing-OD
January 14, 2025Rabenoj-LSR
Rabeprazole Sodium I.P. 20 mg(E.C) + Levosulpride (S.R) 75 mg
Rabenoj-LSR Capsules are a dual-action formulation designed to provide effective relief from acid-related disorders and gastrointestinal motility issues. It combines the acid-suppressing effect of Rabeprazole with the prokinetic action of Levosulpiride, ensuring comprehensive management of acidity and digestive discomfort.
Key Benefits
-
Provides relief from acidity and heartburn
-
Helps manage gastroesophageal reflux disease (GERD)
-
Improves gastric motility and digestion
-
Reduces bloating, nausea, and discomfort
-
Prevents acid reflux and regurgitation
Mechanism of Action
-
Rabeprazole (E.C. 20 mg) reduces gastric acid secretion by inhibiting proton pumps, allowing healing of the stomach lining.
-
Levosulpiride (S.R. 75 mg) enhances gastrointestinal motility, reducing reflux and improving digestion.
Indications
-
GERD (Gastroesophageal Reflux Disease)
-
Acid reflux and hyperacidity
-
Functional dyspepsia
-
Gastritis
-
Bloating and delayed gastric emptying
Dosage
-
As directed by the physician
-
Usually taken once daily before meals
Precautions
-
Use under medical supervision
-
Avoid long-term use without doctor advice
-
May cause dizziness, headache, or gastrointestinal discomfort
-
Inform your doctor if you have kidney or liver issues
-
Avoid alcohol during treatment
Contraindications
-
Hypersensitivity to PPIs or levosulpiride
-
Patients with prolactin-dependent tumors
-
Use with caution in neurological disorders
Common side effects include dizziness, headache, nausea, diarrhea, or constipation. Rarely, it may cause allergic reactions, fatigue, or changes in liver enzymes.
Indicated for gastroesophageal reflux disease (GERD), functional dyspepsia, and related acid reflux conditions.
Use only as prescribed by a healthcare professional. Avoid in cases of known allergies to PPIs or prokinetic agents. Do not discontinue abruptly without consulting your doctor.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Rabenoj-LSR Capsules are a dual-action formulation designed to provide effective relief from acid-related disorders and gastrointestinal motility issues. It combines the acid-suppressing effect of Rabeprazole with the prokinetic action of Levosulpiride, ensuring comprehensive management of acidity and digestive discomfort.
Key Benefits
-
Provides relief from acidity and heartburn
-
Helps manage gastroesophageal reflux disease (GERD)
-
Improves gastric motility and digestion
-
Reduces bloating, nausea, and discomfort
-
Prevents acid reflux and regurgitation
Mechanism of Action
-
Rabeprazole (E.C. 20 mg) reduces gastric acid secretion by inhibiting proton pumps, allowing healing of the stomach lining.
-
Levosulpiride (S.R. 75 mg) enhances gastrointestinal motility, reducing reflux and improving digestion.
Indications
-
GERD (Gastroesophageal Reflux Disease)
-
Acid reflux and hyperacidity
-
Functional dyspepsia
-
Gastritis
-
Bloating and delayed gastric emptying
Dosage
-
As directed by the physician
-
Usually taken once daily before meals
Precautions
-
Use under medical supervision
-
Avoid long-term use without doctor advice
-
May cause dizziness, headache, or gastrointestinal discomfort
-
Inform your doctor if you have kidney or liver issues
-
Avoid alcohol during treatment
Contraindications
-
Hypersensitivity to PPIs or levosulpiride
-
Patients with prolactin-dependent tumors
-
Use with caution in neurological disorders
| Packing |
|---|






